[Ruby_E_Template slug="buzzstream-header"]
Font ResizerAa
Brinks ReportBrinks Report
Search
  • Featured
  • Money Matters
  • Business
  • IPL
  • Technology
  • Automobile
  • Entertainment
  • Sports
  • More
    • People
    • World
    • Health and Wellness
    • Horoscope
  • Today’s News
Have an existing account? Sign In
Follow US
© 2024-2025 Brinks Report. All content, including text, images, and other media, is copyrighted.
BusinessTechnology

FAST India and Indegene Partner to Accelerate Biotech Innovation in India

Dolon Mondal
Last updated: July 3, 2025 12:04 pm
Dolon Mondal
FAST India

India is buzzing with talent. But for years, our best science has struggled to go beyond the lab. Why? Because the path from ideas to real-world impact is full of roadblocks—lack of support, weak links between researchers and industry, and not enough platforms to grow.

This is where FAST India steps in.

The Foundation for Advancing Science and Technology (FAST) India, a bold and focused non-profit, just announced a long-term partnership with Indegene, a global life sciences company. Their goal? To supercharge India’s biotech ecosystem—not with hype, but with real, ground-up innovation.

Together, they want to make sure that breakthrough ideas don’t just sit in research papers. They want to turn them into real products, real solutions, and real change.

From Talk to Transformation

FAST India isn’t just another think tank. It’s a movement.

Their mission? To make India one of the top 3 science nations in the world in the next 10 years. And they’re walking the talk—through big efforts like the India Science Festival, nationwide science contests, and global showcases of Indian R&D.

They also focus on translational research—basically, turning science into something that actually helps people. That’s where their partnership with Indegene comes in.

By building stronger industry-academia bridges, FAST India and Indegene plan to boost research, spark new biotech startups, and train the next generation of science leaders.

Also Read Biocon Gets EU Greenlight, Delivers Breakthrough Denosumab Biosimilars

Why This Matters Now

Let’s be honest—India doesn’t have a tech problem. It has a trust problem.

We trust imported ideas more than our own. We wait for validation from the West. And that’s not just sad—it’s dangerous.

FAST India is flipping that script. Their research digs deep into how Indians feel about science, what stops young people from chasing STEM careers, and how to build better policies that respect local talent.

They release reports, stories, and case studies that help shape India’s future—from classrooms to boardrooms.

In a world chasing trends, India has a choice: follow or lead.

With FAST India and Indegene joining forces, we might finally stop playing catch-up and start building ahead.

“We don’t lack ideas—we’ve just been waiting too long for permission to believe in them.”

And now, we don’t need permission. We just need the will.

Also Read Biocon’s Latest Win: Cheaper Diabetes Treatment Option for India

TAGGED:FAST IndiaIndegeneR&D
Previous Article U.S. Trade Talk Indian Stocks Rise on U.S. Trade Talk Buzz, Markets Eye Bigger Deal
Next Article Alembic Pharma Alembic Pharma to Acquire US-Based Utility Therapeutics for $12 Million
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

You Might Also Like

Google to Let Kids Under 13 Use Gemini Chatbot
Technology

Kids Can Now Use Google’s AI Chatbot — Is It Safe for them? Parents Need to See This

By Ankita Das
Technology

After 40 Years, Microsoft Says Goodbye to Blue Screen of Death – Here’s What Microsoft Is Replacing It ?

By Ankita Das
Teen Accounts: Meta Expands Safety Features to Facebook and Messenger
Technology

Teen Accounts: Meta Expands Safety Features to Facebook and Messenger

By Dolon Mondal
Infosys Q4
Business

Infosys Q4 Dilemma: Earning More, Keeping Less—Is the Growth Model Flawed?

By Dolon Mondal
[Ruby_E_Template slug="buzzstream-footer"]